191 related articles for article (PubMed ID: 30556588)
1. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
Irani M; Siegal E; Jella A; Aster R; Padmanabhan A
Transfusion; 2019 Mar; 59(3):931-934. PubMed ID: 30556588
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
5. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
6. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
7. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
9. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.
Lee CSM; Selvadurai MV; Pasalic L; Yeung J; Konda M; Kershaw GW; Favaloro EJ; Chen VM
J Thromb Haemost; 2022 Apr; 20(4):975-988. PubMed ID: 35038779
[TBL] [Abstract][Full Text] [Related]
10. Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.
Tomer A; Masalunga C; Abshire TC
Am J Hematol; 1999 May; 61(1):53-61. PubMed ID: 10331512
[TBL] [Abstract][Full Text] [Related]
11. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
[TBL] [Abstract][Full Text] [Related]
12. Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection.
Shiuan E; Sharma D; Ely EW; Moodabagil N; Tillman BF
J Thromb Thrombolysis; 2022 Aug; 54(2):367-371. PubMed ID: 35763168
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
14. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
15. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
Warkentin TE; Greinacher A
Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
[TBL] [Abstract][Full Text] [Related]
18. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
19. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
Blood; 2015 Jan; 125(1):155-61. PubMed ID: 25342714
[TBL] [Abstract][Full Text] [Related]
20. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]